$4.27
0.23%
Nasdaq, Sep 25, 12:40 pm EDT. Market open.
ISIN
CA10778Y3023
Symbol
BCTX

BriaCell Therapeutics Corp Stock price

$4.28
+0.82 23.70% 1M
+0.18 4.39% 6M
-2.83 39.80% YTD
-6.08 58.69% 1Y
-822.22 99.48% 3Y
-4.91 53.43% 5Y
-45.22 91.35% 10Y
-374.02 98.87% 20Y
Nasdaq, Closing price Thu, Sep 24 2026
+0.27 6.73%
ISIN
CA10778Y3023
Symbol
BCTX
Industry

Is BriaCell Therapeutics Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
$34.8m
Enterprise Value
$12.0m
Net debt
positive
Cash
$22.8m
Shares outstanding
7.3m
Valuation (TTM | estimate)
P/E
negative
P/S
- | 16.4
EV/Sales
- | 5.7
EV/FCF
negative
P/B
1.5
Financial Health
Equity Ratio
81.8%
Return on Equity
-146.2%
ROCE
-136.4%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $2.1m
EBITDA
$-31.9m
EBIT
$-32.0m
Net Income
$-30.7m
Free Cash Flow
$-31.0m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-31.5%
EBIT
-31.2%
Net Income
-57.9%
Free Cash Flow
-28.7%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow
-
More
EPS
$-4.2
FCF per Share
$-4.3
Short interest
8.3%
Employees
16
Rev per Employee
$0.0

BriaCell Therapeutics Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a BriaCell Therapeutics Corp forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a BriaCell Therapeutics Corp forecast:

Buy
80%
Hold
20%

Financial data from BriaCell Therapeutics Corp

Apr '26
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 6.21 6.21
6% 6%
-
- Research and Development Expense 26 26
39% 39%
-
-32 -32
32% 32%
-
- Depreciation and Amortization 0.11 0.11
27% 27%
-
EBIT (Operating Income) EBIT -32 -32
31% 31%
-
Net Profit -31 -31
58% 58%
-

In millions USD.

Don't miss a Thing! We will send you all news about BriaCell Therapeutics Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BriaCell Therapeutics Corp Stock News

Neutral
GlobeNewsWire
●
11 days ago
PHILADELPHIA and VANCOUVER, British Columbia, Sept. 14, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announces that the independent Data Safety Monitoring Board (DSMB) has issued its seventh consecutive positive recommendation ...
Neutral
GlobeNewsWire
●
17 days ago
PHILADELPHIA and VANCOUVER, British Columbia, Sept. 08, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced that Memorial Sloan Kettering Cancer Center (MSK) has joined BriaCell's ongoing pivotal Phase 3 study of Bria-...
Neutral
GlobeNewsWire
●
about one month ago
Cell-based immunotherapy program is designed to harness patients' own immune systems Bria-MEL+ is a personalized, off-the-shelf immunotherapy vaccine candidate intended to enable patient specific treatment without individualized manufacturing Program builds on BriaCell's experience in metastatic breast cancer and prostate cancer, further expanding its therapeutic vaccine platform Melanoma remai...
More BriaCell Therapeutics Corp News

Company Profile

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

Head office Canada
CEO Dr. Williams
Employees 16
Founded 2006
Website briacell.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today